First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2012-04-09 16:49:25Open Document File Size: 262,42 KBShare Result on FacebookCityCincinnati / Boston / New York / Washington / D.C. / /CompanyEli Lilly / All Inc. / Warner-Lambert Co. LLC / IMS HEALTH INC. ET / PREVENTING WIDESPREAD ILLEGAL OFFLABEL PROMOTION / Pfizer / Prescription Access Litigation LLC / Inspector General / CURIAE1 Community Catalyst Inc. / The Kaiser Family Fund. / Verispan / SDI / /CountryUnited States / /CurrencyUSD / / /EventM&A / /FacilitySupreme Court / /IndustryTermillegal off-label promotional communications / /OrganizationOff-label Prescribing Among Office / Kaiser Family Fund / Supreme Court / United States Court of Appeals / School of Law / Drug and Device Promotion / office of the Inspector General / AMICI CURIAE AFSCME DISTRICT COUNCIL / Seton Hall Univ. / U.S. Attorney's Office / FDA / AFSCME District Council / Center for Health and Pharmaceutical Law / /PersonWells G. Wilkinson / G. Caleb Alexander / Sector Payors / David C. Radley / David Evans / Jim Edwards / / /PositionCounsel / Georgia John Maheras Counsel / Record Counsel / contractor / Counsel for Amicus AFSCME Dist / United States Attorney / /ProductBextra / Off-Label Drug / Warner-Lambert Acquisition Has Side Effects / /ProgrammingLanguageDC / /ProvinceOrStateAFSCME DISTRICT / New York / District of Columbia / Massachusetts / /PublishedMediumUSA Today / /Technologyhtml / pdf / /URLhttp /SocialTag |